PANOPTES is the acronym of a research project entitled ‘Peptide-based Nanoparticles as Ocular Drug Delivery Vehicles’.  The project is supported by funding from the Nanosciences, Nanotechnologies, Materials & New Production Technologies (NMP) Theme of the Cooperation Programme, under the 7th Research Framework Programme of the European Union.



A symposium on ‘Peptide-based Materials for Nanomedicine’ was organised by the PANOPTES project as part of the 247th American Chemical Society National Meeting in Dallas (March 16-20, 2014). The symposium was one of several organised by the ACS POLY division, and was well attended throughout the conference. Invited speakers included

    Prof Tim Deming, UCLA

    Prof Harm-Anton Klok, École Polytechnique Fédérale de Lausanne

    Prof Sam Stupp, Northwestern University

    Dr Michael Bevilacqua, Amicrobe Inc.

    Dr Andreas Heise, Dublin City University

In addition, results from the PANOPTES project were disseminated via lectures given by Mengmeng Zong (DSM), George Mihov (DSM), Neil Cameron (Durham), Nanda Smits (Nijmegen) and Vanessa Andrés-Guerrero (Madrid).

Previous News Items

The PANOPTES project organised a very successful session on ophthalmic drug delivery at the European Biomaterials Congress in Madrid, 8-12 September 2013.  As well as talks from PANOPTES researchers, there were lectures from the following invited speakers:

    Prof Uday Kompella, Dept. of Pharmaceutical Sciences, University of Colorado, USA

    Prof Stefaan de Smedt, Faculty of Pharmaceutical Sciences, University of Ghent, Belgium

The session was very well received and enjoyed by all who attended.

Future PANOPTES meetings (posted 22nd Oct 2013):

    Madrid, Spain, April 23-24 2014

    Maastricht, The Netherlands, October 2014

Next PANOPTES meeting: Helsinki, Finland, 25-26 April 2012 (posted 28th Feb 2012)

Next PANOPTES meeting: Madrid, Spain, 21-22 November 2011 (posted 30th June 2011)

New post-doc appointed at DSM: Dr Meng Meng Zhong started in April 2011 (posted 2nd June 2011)

New post-doc appointed at Durham: Dr Sarah Hehir starts on March 1st 2011 (posted 23rd Feb 2011)

Next PANOPTES meeting: April 7-8, 2011, Maastricht, the Netherlands (posted 23rd Feb 2011)

The PANOPTES project will develop novel peptide-based nanomaterials to bring about sustained drug delivery to the posterior segment of the eye.  Disorders affecting the posterior segment, which cause visual impairment and blindness, are occurring at an increasing rate as the European population ages.  For example, there are currently about 6.5 million Europeans suffering from late stage age-related macular degeneration (AMD), a disorder of the posterior segment. The consortium consists of research groups from five leading European universities together with the Dutch performance materials and life sciences company DSM.